03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Aldactide* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Food & Drug Corporation |
Distributor | Food & Drug Corporation |
Laboratory | Pfizer |
Responsible Party | Searle |
Origin | UK |
Manufacturer | Searle |
Origin | UK |
ATC | C03EA |
Revision Date | 01/01/2000 |
Aldactide* :
Aldactide* :
Aldactide* :
Aldactide* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Aldactide* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agranulocytosis | Not known |
Alopecia | Not known |
Anaphylactoid reactions | Not known |
Angle closure glaucoma | Not known |
Aplastic anemia | Not known |
Benign breast neoplasm | Not known |
Blood dyscrasia | Not known |
Breast enlargement | Not known |
Breast pain | Not known |
Confusional state | Not known |
Dizziness | Not known |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Electrolyte imbalance | Not known |
Erectile dysfunction | Not known |
Gastrointestinal disorders | Not known |
Gynecomastia (Gynaecomastia) | Not known |
Headache | Not known |
Hepatic function abnormal | Not known |
Hypercalcaemia | Not known |
Hyperkalaemia | Not known |
Hypertrichosis | Not known |
Jaundice | Not known |
Leucopenia (Leukopenia) | Not known |
Libido disorder | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Malaise | Not known |
Menstrual disorder | Not known |
Muscle spasms | Not known |
Myopia | Not known |
Nausea | Not known |
Orthostatic hypotension | Not known |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Not known |
Photosensitivity reaction | Not known |
Pruritus | Not known |
Purpura | Not known |
Reactivation of cutaneous lupus erythematosus | Not known |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Restlessness | Not known |
Serum lipids increased | Not known |
Skin rash | Not known |
Stevens-Johnson syndrome | Not known |
Systemic lupus erythematosus | Not known |
Systemic lupus erythematosus syndrome aggravated | Not known |
Thrombocytopenia (Thrombopenia) | Not known |
Urticaria | Not known |
Vasculitis | Not known |
Vertigo | Not known |
Weakness | Not known |
Xanthopsia | Not known |
Aldactide* :
Different Units By MoH Code
Aldactide* MoH 776 :
Form | Tablet |
Package Size | Box of 40 |
Strength | 25mg/25mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 25672 |
Submission date | 01/01/1984 |
Registration Year | 1984 |
Archived Date | 2014 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 40 | |
● Public Price: | 33 AED | ( 797,313.00 LBP ) |
● Pack size unit used: | 40 | |
● Cost/Unit: | 0,825 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 26.89 AED | ( 649689.29 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 40's | |
● Public Price: | 33 AED | ( 797,313.00 LBP ) |
● Pack size unit used: | 40 | |
● Cost/Unit: | 0,825 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 26.89 AED | ( 649689.29 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 40 | |
● Public Price: | 32.95 SAR | ( 778,938.00 LBP ) |
● Pack size unit used: | 40 | |
● Cost/Unit: | 0,8238 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 100 | |
● Public Price: | 20.23 GBP | ( 2,299,119.27 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,2023 GBP | ( 0.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File